fig2
Figure 2. Microbial enrichment during immunotherapy. This figure illustrates the effects of different members of the gastrointestinal microbiota on ICI treatments. The studies referenced are by Temraz et al.[119], Frankel et al.[120], Routy et al.[121], Chaput et al.[122], and Matson et al.[123]. ICI: Immune checkpoint inhibitor.
